The Center for Medicare and Medicaid Innovation is accelerating the implementation schedule for a payment demonstration testing a multi-state, outcomes-based contracting approach for cell and gene therapies and now expects to begin in 2025 instead of 2026.
Key Takeaways
-
Cost concerns among Medicaid programs is accelerating CMMI’s plans to launch a demonstration involve multi-state outcomes-based contracts for cell and gene therapy.
The demonstration is one of three models for lowering prescription drug costs that CMMI is working on in response to...







